CAS RN: 331647-05-3
8-BROMO-2,4-DICHLOROQUINAZOLINE
Product Availability
Choose a grade to view its available package options.
4 package records4 with current stock2 grade groups
| Batch No. | Package | Availability | Warehouse | Lead Time | Inquiry |
| Batchno.20260116 |
1g |
In stock |
| | Inquiry |
| Batchno.20251028 |
250mg |
In stock |
| | Inquiry |
| Batchno.20251226 |
5g |
In stock |
| | Inquiry |
| Batch No. | Package | Availability | Warehouse | Lead Time | Inquiry |
| Batchno.20250714 |
250mg / 1g / 5g / 10g / 25g |
Confirm by inquiry |
Shanghai | 8-10 business days | Inquiry |
GET A QUOTE
Packaging options, recorded purity, stock quantity and ship-from location below are generated from the current factory data table for this CAS.
- Pack sizes on record: 1g, 10g, 25g, 5g, 100g, 0.25g
- Available purity: >98%
- Inventory rows with stock: 6
- Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 331647-05-3
| Pack Size |
Recorded Purity |
Available Qty |
Ship From |
Inquiry |
| 1g |
>98% |
5
In Stock
|
Shanghai |
Inquiry |
| 10g |
>98% |
5
In Stock
|
Shenzhen |
Inquiry |
| 25g |
>98% |
3
In Stock
|
Beijing |
Inquiry |
| 5g |
>98% |
2
In Stock
|
Shenzhen |
Inquiry |
| 100g |
>98% |
2
In Stock
|
Shanghai |
Inquiry |
| 0.25g |
>98% |
1
In Stock
|
Shanghai |
Inquiry |
331647-05-3 / 8-bromo-2,4-dichloroquinazoline
Standard CAS: 331647-05-3
Multi CAS: No
Basic Information
CAS
331647-05-3
Multi CAS
No
Molecular Formula
C8H3BRCL2N2
Molecular Weight
277.930000
Exact Mass
275.885670
InChI
InChI=1S/C8H3BrCl2N2/c9-5-3-1-2-4-6(5)12-8(11)13-7(4)10/h1-3H
InChIKey
BHXJPWCPEFXWMH-UHFFFAOYSA-N
Computed Properties
Structural Parameters
Heavy atom count
13
Aromatic heavy atom count
10
H-bond acceptors
2
Molar refractivity
57.26
TPSA
25.78
LogP / Solubility
WLOGP
3.7
MLOGP
3.26
XLogP3
4.2
Consensus LogP
3.72
Log S (ESOL)
-4.46
Class (ESOL)
Slightly soluble
Log S (Ali)
-4.51
Class (Ali)
Slightly soluble
Log S (SILICOS-IT)
-4.54
Class (SILICOS-IT)
Slightly soluble
ADME
GI absorption
High
BBB permeant
Yes
P-gp substrate
No
CYP1A2 inhibitor
Yes
CYP2C19 inhibitor
Yes
CYP2C9 inhibitor
No
CYP2D6 inhibitor
No
CYP3A4 inhibitor
No
Log Kp (skin permeation)
-1.79
Drug-likeness / Medicinal Chemistry
Lipinski
Yes
Ghose
No
Veber
Yes
Egan
Yes
Muegge
Yes
Bioavailability score
0.55
Leadlikeness
No
Synthetic Accessibility
1.5